Search

everythinglearnresearchcommunity

for

Search:↓

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

New insights into cell communication in psoriasis suggest innovative drug treatments.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Methylphenidate can cause hair loss, which stops when the drug is discontinued.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Hair follicles prevent NK cell attacks to avoid hair loss.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.